Global and United States Medical Cannabis Market Report & Forecast 2022-2028

Publisher Name :
Date: 07-Jun-2022
No. of pages: 109
Inquire Before Buying

Medical Cannabis market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Medical Cannabis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Medical Cannabis market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

- Tetrahydrocannabinol (THC)

- Cannabidiol (CBD)

Segment by Application

- Pain

- Arthritis

- Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- BOL Pharma

- Tilray

- Medreleaf Corporation

- Aurora Cannabis, Inc

- Canopy Growth Corporation

- Insys Therapeutics, Inc

- Aphria, Inc

- MGC Pharmaceuticals Limited

- GW Pharmaceuticals, plc

- Medical Marijuana Inc

- Medipharm Labs

Global and United States Medical Cannabis Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Medical Cannabis Product Introduction
1.2 Global Medical Cannabis Outlook 2017 VS 2022 VS 2028
1.2.1 Global Medical Cannabis Sales in US$ Million for the Year 2017-2028
1.2.2 Global Medical Cannabis Sales in Volume for the Year 2017-2028
1.3 United States Medical Cannabis Outlook 2017 VS 2022 VS 2028
1.3.1 United States Medical Cannabis Sales in US$ Million for the Year 2017-2028
1.3.2 United States Medical Cannabis Sales in Volume for the Year 2017-2028
1.4 Medical Cannabis Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Medical Cannabis in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Medical Cannabis Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Medical Cannabis Market Dynamics
1.5.1 Medical Cannabis Industry Trends
1.5.2 Medical Cannabis Market Drivers
1.5.3 Medical Cannabis Market Challenges
1.5.4 Medical Cannabis Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Medical Cannabis Market Segment by Type
2.1.1 Tetrahydrocannabinol (THC)
2.1.2 Cannabidiol (CBD)
2.2 Global Medical Cannabis Market Size by Type
2.2.1 Global Medical Cannabis Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Medical Cannabis Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Medical Cannabis Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Medical Cannabis Market Size by Type
2.3.1 United States Medical Cannabis Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Medical Cannabis Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Medical Cannabis Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Medical Cannabis Market Segment by Application
3.1.1 Pain
3.1.2 Arthritis
3.1.3 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
3.1.4 Others
3.2 Global Medical Cannabis Market Size by Application
3.2.1 Global Medical Cannabis Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Medical Cannabis Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Medical Cannabis Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Medical Cannabis Market Size by Application
3.3.1 United States Medical Cannabis Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Medical Cannabis Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Medical Cannabis Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Medical Cannabis Competitor Landscape by Company
4.1 Global Medical Cannabis Market Size by Company
4.1.1 Top Global Medical Cannabis Manufacturers Ranked by Revenue (2021)
4.1.2 Global Medical Cannabis Revenue by Manufacturer (2017-2022)
4.1.3 Global Medical Cannabis Sales by Manufacturer (2017-2022)
4.1.4 Global Medical Cannabis Price by Manufacturer (2017-2022)
4.2 Global Medical Cannabis Concentration Ratio (CR)
4.2.1 Medical Cannabis Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Medical Cannabis in 2021
4.2.3 Global Medical Cannabis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Medical Cannabis Manufacturing Base Distribution, Product Type
4.3.1 Global Medical Cannabis Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Medical Cannabis Product Type
4.3.3 Date of International Manufacturers Enter into Medical Cannabis Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Medical Cannabis Market Size by Company
4.5.1 Top Medical Cannabis Players in United States, Ranked by Revenue (2021)
4.5.2 United States Medical Cannabis Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Medical Cannabis Sales by Players (2020, 2021 & 2022)
5 Global Medical Cannabis Market Size by Region
5.1 Global Medical Cannabis Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Medical Cannabis Market Size in Volume by Region (2017-2028)
5.2.1 Global Medical Cannabis Sales in Volume by Region: 2017-2022
5.2.2 Global Medical Cannabis Sales in Volume Forecast by Region (2023-2028)
5.3 Global Medical Cannabis Market Size in Value by Region (2017-2028)
5.3.1 Global Medical Cannabis Sales in Value by Region: 2017-2022
5.3.2 Global Medical Cannabis Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Medical Cannabis Market Size YoY Growth 2017-2028
6.1.2 North America Medical Cannabis Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Medical Cannabis Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Medical Cannabis Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Medical Cannabis Market Size YoY Growth 2017-2028
6.3.2 Europe Medical Cannabis Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Medical Cannabis Market Size YoY Growth 2017-2028
6.4.2 Latin America Medical Cannabis Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Medical Cannabis Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Medical Cannabis Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 BOL Pharma
7.1.1 BOL Pharma Corporation Information
7.1.2 BOL Pharma Description and Business Overview
7.1.3 BOL Pharma Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.1.4 BOL Pharma Medical Cannabis Products Offered
7.1.5 BOL Pharma Recent Development
7.2 Tilray
7.2.1 Tilray Corporation Information
7.2.2 Tilray Description and Business Overview
7.2.3 Tilray Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Tilray Medical Cannabis Products Offered
7.2.5 Tilray Recent Development
7.3 Medreleaf Corporation
7.3.1 Medreleaf Corporation Corporation Information
7.3.2 Medreleaf Corporation Description and Business Overview
7.3.3 Medreleaf Corporation Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Medreleaf Corporation Medical Cannabis Products Offered
7.3.5 Medreleaf Corporation Recent Development
7.4 Aurora Cannabis, Inc
7.4.1 Aurora Cannabis, Inc Corporation Information
7.4.2 Aurora Cannabis, Inc Description and Business Overview
7.4.3 Aurora Cannabis, Inc Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Aurora Cannabis, Inc Medical Cannabis Products Offered
7.4.5 Aurora Cannabis, Inc Recent Development
7.5 Canopy Growth Corporation
7.5.1 Canopy Growth Corporation Corporation Information
7.5.2 Canopy Growth Corporation Description and Business Overview
7.5.3 Canopy Growth Corporation Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Canopy Growth Corporation Medical Cannabis Products Offered
7.5.5 Canopy Growth Corporation Recent Development
7.6 Insys Therapeutics, Inc
7.6.1 Insys Therapeutics, Inc Corporation Information
7.6.2 Insys Therapeutics, Inc Description and Business Overview
7.6.3 Insys Therapeutics, Inc Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Insys Therapeutics, Inc Medical Cannabis Products Offered
7.6.5 Insys Therapeutics, Inc Recent Development
7.7 Aphria, Inc
7.7.1 Aphria, Inc Corporation Information
7.7.2 Aphria, Inc Description and Business Overview
7.7.3 Aphria, Inc Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Aphria, Inc Medical Cannabis Products Offered
7.7.5 Aphria, Inc Recent Development
7.8 MGC Pharmaceuticals Limited
7.8.1 MGC Pharmaceuticals Limited Corporation Information
7.8.2 MGC Pharmaceuticals Limited Description and Business Overview
7.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.8.4 MGC Pharmaceuticals Limited Medical Cannabis Products Offered
7.8.5 MGC Pharmaceuticals Limited Recent Development
7.9 GW Pharmaceuticals, plc
7.9.1 GW Pharmaceuticals, plc Corporation Information
7.9.2 GW Pharmaceuticals, plc Description and Business Overview
7.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.9.4 GW Pharmaceuticals, plc Medical Cannabis Products Offered
7.9.5 GW Pharmaceuticals, plc Recent Development
7.10 Medical Marijuana Inc
7.10.1 Medical Marijuana Inc Corporation Information
7.10.2 Medical Marijuana Inc Description and Business Overview
7.10.3 Medical Marijuana Inc Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Medical Marijuana Inc Medical Cannabis Products Offered
7.10.5 Medical Marijuana Inc Recent Development
7.11 Medipharm Labs
7.11.1 Medipharm Labs Corporation Information
7.11.2 Medipharm Labs Description and Business Overview
7.11.3 Medipharm Labs Medical Cannabis Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Medipharm Labs Medical Cannabis Products Offered
7.11.5 Medipharm Labs Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Medical Cannabis Industry Chain Analysis
8.2 Medical Cannabis Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Medical Cannabis Distributors
8.3 Medical Cannabis Production Mode & Process
8.4 Medical Cannabis Sales and Marketing
8.4.1 Medical Cannabis Sales Channels
8.4.2 Medical Cannabis Distributors
8.5 Medical Cannabis Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Medical Cannabis CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Medical Cannabis Market Trends
Table 3. Medical Cannabis Market Drivers
Table 4. Medical Cannabis Market Challenges
Table 5. Medical Cannabis Market Restraints
Table 6. Global Medical Cannabis Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Medical Cannabis Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Medical Cannabis Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Medical Cannabis Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Medical Cannabis Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Medical Cannabis Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Medical Cannabis Revenue Share by Manufacturer, 2017-2022
Table 13. Global Medical Cannabis Sales by Manufacturer, (MT), 2017-2022
Table 14. Global Medical Cannabis Sales Share by Manufacturer, 2017-2022
Table 15. Global Medical Cannabis Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Medical Cannabis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Medical Cannabis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Cannabis as of 2021)
Table 18. Top Players of Medical Cannabis in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Medical Cannabis Product Type
Table 20. Date of International Manufacturers Enter into Medical Cannabis Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Medical Cannabis Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Medical Cannabis Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Medical Cannabis Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Medical Cannabis Sales by Players, (MT), 2020, 2021 & 2022
Table 26. United States Medical Cannabis Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Medical Cannabis Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Medical Cannabis Sales in Volume by Region (2017-2022) & (MT)
Table 29. Global Medical Cannabis Sales in Volume Forecast by Region (2023-2028) & (MT)
Table 30. Global Medical Cannabis Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Medical Cannabis Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Medical Cannabis Sales in Volume by Country (2017-2028) & (MT)
Table 33. North America Medical Cannabis Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Medical Cannabis Sales in Volume by Region (2017-2028) & (MT)
Table 35. Asia Pacific Medical Cannabis Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Medical Cannabis Sales in Volume by Country (2017-2028) & (MT)
Table 37. Europe Medical Cannabis Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Medical Cannabis Sales in Volume by Country (2017-2028) & (MT)
Table 39. Latin Americaa Medical Cannabis Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Medical Cannabis Sales in Volume by Country (2017-2028) & (MT)
Table 41. Middle East and Africa Medical Cannabis Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. BOL Pharma Corporation Information
Table 43. BOL Pharma Description and Business Overview
Table 44. BOL Pharma Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. BOL Pharma Medical Cannabis Product
Table 46. BOL Pharma Recent Development
Table 47. Tilray Corporation Information
Table 48. Tilray Description and Business Overview
Table 49. Tilray Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Tilray Product
Table 51. Tilray Recent Development
Table 52. Medreleaf Corporation Corporation Information
Table 53. Medreleaf Corporation Description and Business Overview
Table 54. Medreleaf Corporation Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Medreleaf Corporation Product
Table 56. Medreleaf Corporation Recent Development
Table 57. Aurora Cannabis, Inc Corporation Information
Table 58. Aurora Cannabis, Inc Description and Business Overview
Table 59. Aurora Cannabis, Inc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Aurora Cannabis, Inc Product
Table 61. Aurora Cannabis, Inc Recent Development
Table 62. Canopy Growth Corporation Corporation Information
Table 63. Canopy Growth Corporation Description and Business Overview
Table 64. Canopy Growth Corporation Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Canopy Growth Corporation Product
Table 66. Canopy Growth Corporation Recent Development
Table 67. Insys Therapeutics, Inc Corporation Information
Table 68. Insys Therapeutics, Inc Description and Business Overview
Table 69. Insys Therapeutics, Inc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Insys Therapeutics, Inc Product
Table 71. Insys Therapeutics, Inc Recent Development
Table 72. Aphria, Inc Corporation Information
Table 73. Aphria, Inc Description and Business Overview
Table 74. Aphria, Inc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Aphria, Inc Product
Table 76. Aphria, Inc Recent Development
Table 77. MGC Pharmaceuticals Limited Corporation Information
Table 78. MGC Pharmaceuticals Limited Description and Business Overview
Table 79. MGC Pharmaceuticals Limited Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. MGC Pharmaceuticals Limited Product
Table 81. MGC Pharmaceuticals Limited Recent Development
Table 82. GW Pharmaceuticals, plc Corporation Information
Table 83. GW Pharmaceuticals, plc Description and Business Overview
Table 84. GW Pharmaceuticals, plc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. GW Pharmaceuticals, plc Product
Table 86. GW Pharmaceuticals, plc Recent Development
Table 87. Medical Marijuana Inc Corporation Information
Table 88. Medical Marijuana Inc Description and Business Overview
Table 89. Medical Marijuana Inc Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Medical Marijuana Inc Product
Table 91. Medical Marijuana Inc Recent Development
Table 92. Medipharm Labs Corporation Information
Table 93. Medipharm Labs Description and Business Overview
Table 94. Medipharm Labs Medical Cannabis Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Medipharm Labs Product
Table 96. Medipharm Labs Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Medical Cannabis Customers List
Table 100. Medical Cannabis Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Cannabis Product Picture
Figure 2. Global Medical Cannabis Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Medical Cannabis Market Size 2017-2028 (US$ Million)
Figure 4. Global Medical Cannabis Sales 2017-2028 (MT)
Figure 5. United States Medical Cannabis Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Medical Cannabis Market Size 2017-2028 (US$ Million)
Figure 7. United States Medical Cannabis Sales 2017-2028 (MT)
Figure 8. United States Medical Cannabis Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Medical Cannabis Market Share in Global, in Volume (MT) 2017-2028
Figure 10. Medical Cannabis Report Years Considered
Figure 11. Product Picture of Tetrahydrocannabinol (THC)
Figure 12. Product Picture of Cannabidiol (CBD)
Figure 13. Global Medical Cannabis Market Share by Type in 2022 & 2028
Figure 14. Global Medical Cannabis Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Medical Cannabis Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Medical Cannabis Sales by Type (2017-2028) & (MT)
Figure 17. Global Medical Cannabis Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Medical Cannabis Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Medical Cannabis Market Share by Type in 2022 & 2028
Figure 20. United States Medical Cannabis Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Medical Cannabis Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Medical Cannabis Sales by Type (2017-2028) & (MT)
Figure 23. United States Medical Cannabis Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Medical Cannabis Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of Pain
Figure 26. Product Picture of Arthritis
Figure 27. Product Picture of Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Figure 28. Product Picture of Others
Figure 29. Global Medical Cannabis Market Share by Application in 2022 & 2028
Figure 30. Global Medical Cannabis Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Medical Cannabis Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Medical Cannabis Sales by Application (2017-2028) & (MT)
Figure 33. Global Medical Cannabis Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Medical Cannabis Price by Application (2017-2028) & (USD/MT)
Figure 35. United States Medical Cannabis Market Share by Application in 2022 & 2028
Figure 36. United States Medical Cannabis Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Medical Cannabis Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Medical Cannabis Sales by Application (2017-2028) & (MT)
Figure 39. United States Medical Cannabis Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Medical Cannabis Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
Figure 42. North America Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
Figure 46. Europe Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
Figure 53. Asia-Pacific Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
Figure 65. Latin America Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Medical Cannabis Sales in Volume Growth Rate 2017-2028 (MT)
Figure 70. Middle East & Africa Medical Cannabis Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Medical Cannabis Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Medical Cannabis Value Chain
Figure 75. Medical Cannabis Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs